Robert Matthew Lutz
CIK 1786203 · Chief Operating Officer · last filed 2025-12-16
Robert Matthew Lutz is a Chief Operating Officer who has filed 13 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing shows the insider had shares withheld for taxes covering $468.9K of SVRA on Dec 16, 2025. Across all open-market trades the lifetime net is −$8.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.72M
3
13
-$8.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SVRA | Chief Operating Officer | 293,977 | $5.26 | $1.55M | $0 | 5 | 2025-12-16 |
| IBIO | See Remarks | 102,165 | $1.69 | $172.7K | -$8.5K | 5 | 2022-11-15 |
| Strongbridge Biopharma plc (SBBP) Delisted | Chief Financial Officer | 181,333 | $2.00 | $362.7K | $0 | 3 | 2021-02-23 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-16 | SVRA | Tax (F) | −67,760 | -$468.9K | EDGAR |
| 2025-02-14 | SVRA | Tax (F) | −38,263 | -$108.3K | EDGAR |
| 2024-12-16 | SVRA | Grant (A) | +100,000 | $0 | EDGAR |
| 2023-12-15 | SVRA | Grant (A) | +160,000 | $0 | EDGAR |
| 2023-02-28 | SVRA | Grant (A) | +140,000 | $0 | EDGAR |
| 2022-11-15 | IBIO | Grant (A) | +100,057 | $0 | EDGAR |
| 2022-08-31 | IBIO | Grant (A) | — | $0 | EDGAR |
| 2022-03-14 | IBIO | Sell (S) | −24,625 | -$8.5K | EDGAR |
| 2021-08-25 | IBIO | Grant (A) | — | $0 | EDGAR |
| 2021-03-04 | IBIO | Grant (A) | +232,000 | $0 | EDGAR |